Form 4/A for AIM AIM ImmunoTech Inc.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-01-15 · accession 0001493152-25-007738 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-02-20 | 2025-01-15 | AIM | MITCHELL WILLIAM M | Dir | A - Grant | $0.19 | +27.4K | 172.3K | +19% | +$5,208 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | A | A | 27,412 | $0.19 | 172,266 | D | — | — | (F2) This amended Form 4/A is filed to correct the D on the original filing to A. The shares were acquired, not disposed (F1) These shares are issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan. |